PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 199 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,605,000 | -10.2% | 142,579 | -4.8% | 0.01% | -16.7% |
| Q3 2016 | $5,126,000 | +12.2% | 149,803 | +10.6% | 0.01% | 0.0% |
| Q2 2016 | $4,569,000 | -31.7% | 135,455 | +7.3% | 0.01% | -33.3% |
| Q1 2016 | $6,689,000 | -29.0% | 126,249 | +2.9% | 0.01% | -25.0% |
| Q4 2015 | $9,417,000 | +87.0% | 122,637 | +0.1% | 0.01% | +71.4% |
| Q3 2015 | $5,035,000 | -42.5% | 122,502 | -1.0% | 0.01% | -36.4% |
| Q2 2015 | $8,750,000 | +0.1% | 123,726 | +25.8% | 0.01% | 0.0% |
| Q1 2015 | $8,742,000 | +1.7% | 98,388 | +1.5% | 0.01% | 0.0% |
| Q4 2014 | $8,596,000 | -12.2% | 96,960 | -4.0% | 0.01% | -21.4% |
| Q3 2014 | $9,787,000 | +9.4% | 100,976 | +3.7% | 0.01% | +16.7% |
| Q2 2014 | $8,948,000 | +68.1% | 97,407 | +28.1% | 0.01% | +50.0% |
| Q1 2014 | $5,323,000 | +22.3% | 76,060 | +0.4% | 0.01% | +33.3% |
| Q4 2013 | $4,354,000 | +16.5% | 75,733 | -2.5% | 0.01% | 0.0% |
| Q3 2013 | $3,736,000 | +77.1% | 77,702 | +6.8% | 0.01% | +50.0% |
| Q2 2013 | $2,110,000 | – | 72,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |